Altshuler Shaham Ltd Invests $46,000 in Cardinal Health, Inc. (NYSE:CAH)

Altshuler Shaham Ltd purchased a new stake in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 452 shares of the company’s stock, valued at approximately $46,000.

Several other institutional investors also recently bought and sold shares of CAH. Ameriprise Financial Inc. grew its holdings in Cardinal Health by 82.2% in the third quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company’s stock valued at $358,390,000 after purchasing an additional 1,862,291 shares during the period. Northern Trust Corp grew its holdings in Cardinal Health by 0.9% in the third quarter. Northern Trust Corp now owns 3,340,547 shares of the company’s stock valued at $290,026,000 after purchasing an additional 28,412 shares during the period. Pacer Advisors Inc. boosted its stake in shares of Cardinal Health by 17.5% in the fourth quarter. Pacer Advisors Inc. now owns 2,619,561 shares of the company’s stock worth $264,052,000 after acquiring an additional 389,431 shares during the last quarter. AQR Capital Management LLC boosted its stake in shares of Cardinal Health by 0.8% in the third quarter. AQR Capital Management LLC now owns 2,496,531 shares of the company’s stock worth $216,749,000 after acquiring an additional 19,287 shares during the last quarter. Finally, California Public Employees Retirement System boosted its stake in shares of Cardinal Health by 118.9% in the fourth quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company’s stock worth $152,816,000 after acquiring an additional 823,520 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have commented on CAH. UBS Group lifted their target price on Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Leerink Partnrs reissued an “outperform” rating on shares of Cardinal Health in a research report on Monday, February 26th. Wells Fargo & Company decreased their target price on Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research report on Monday, April 29th. Robert W. Baird reduced their price objective on Cardinal Health from $134.00 to $128.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Finally, SVB Leerink began coverage on Cardinal Health in a research note on Monday, February 26th. They set an “outperform” rating and a $125.00 target price for the company. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $105.79.

View Our Latest Report on CAH

Cardinal Health Stock Down 2.3 %

Shares of CAH traded down $2.27 on Wednesday, reaching $97.45. The stock had a trading volume of 2,280,585 shares, compared to its average volume of 2,284,416. The firm has a market capitalization of $23.74 billion, a PE ratio of 43.31, a PEG ratio of 1.01 and a beta of 0.71. The firm has a 50-day moving average of $108.38 and a 200 day moving average of $105.21. Cardinal Health, Inc. has a twelve month low of $80.90 and a twelve month high of $116.04.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $1.95 by $0.13. The business had revenue of $54.90 billion for the quarter, compared to analysts’ expectations of $56.05 billion. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.74 EPS. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.34 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 2.08%. The ex-dividend date is Monday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.50. Cardinal Health’s dividend payout ratio is 88.89%.

Cardinal Health Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Further Reading

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.